C07F5/05

METHOD FOR PRODUCING COPOLYMER OF ALLYL MONOMER HAVING POLAR GROUP

The present invention pertains to a method for producing a copolymer of ethylene and an allyl monomer having a polar group represented by general formula (1), or a copolymer of ethylene, an allyl monomer having a polar group represented by general formula (1), and other monomers, wherein the copolymer is produced in the presence of a boron compound having a boron-hydrogen bond or a boron-carbon bond (for example, a compound represented by general formula (2)) by using a metal complex represented by general formula (C1) as a polymerization catalyst (the symbols in the formulas are as described in the description). According to the present invention, a copolymer of ethylene and an allyl monomer can be efficiently produced with high catalytic activity, wherein the copolymer has a polar group and can be used in various applications.

##STR00001##

Antiviral and antibacteria agents based on quaternary ammonium compound complexed with boric acid and its derivatives

The present document describes compounds resulting from the complexation of quaternary ammonium compounds with boric acid and/or its derivatives, and methods of making the same, and methods of using the same for the treatment of pathogenic infections.

Antiviral and antibacteria agents based on quaternary ammonium compound complexed with boric acid and its derivatives

The present document describes compounds resulting from the complexation of quaternary ammonium compounds with boric acid and/or its derivatives, and methods of making the same, and methods of using the same for the treatment of pathogenic infections.

PROTEASOME INHIBITORS
20200407376 · 2020-12-31 ·

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

PROTEASOME INHIBITORS
20200407376 · 2020-12-31 ·

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

Boron-Containing Compounds, Compositions, And Methods For The Deposition Of A Boron Containing Films
20200365401 · 2020-11-19 · ·

Described herein are boron-containing precursor compounds, and compositions and methods comprising same, for forming boron-containing films. In one aspect, the film is deposited from at least one precursor having the following Formula I or II described herein.

##STR00001##

Boron-Containing Compounds, Compositions, And Methods For The Deposition Of A Boron Containing Films
20200365401 · 2020-11-19 · ·

Described herein are boron-containing precursor compounds, and compositions and methods comprising same, for forming boron-containing films. In one aspect, the film is deposited from at least one precursor having the following Formula I or II described herein.

##STR00001##

Catalyst Systems Comprising Carborane Cocatalysts
20200331933 · 2020-10-22 ·

Disclosed are catalyst systems comprising the reaction product of at least the following A) a procatalyst; and B) at least one cocatalyst structure selected from the following i) through iii), i) at least one cocatalyst comprising an anion having Structure 1 as shown below (Structure 1) as described herein; or ii) at least one cocatalyst comprising an anion having Structure 2 as shown below (Structure 2) as described herein; or iii) a combination of i and ii.

##STR00001##

Catalyst Systems Comprising Carborane Cocatalysts
20200331933 · 2020-10-22 ·

Disclosed are catalyst systems comprising the reaction product of at least the following A) a procatalyst; and B) at least one cocatalyst structure selected from the following i) through iii), i) at least one cocatalyst comprising an anion having Structure 1 as shown below (Structure 1) as described herein; or ii) at least one cocatalyst comprising an anion having Structure 2 as shown below (Structure 2) as described herein; or iii) a combination of i and ii.

##STR00001##

NOVEL HIGH VOLTAGE 10, 11, AND 12-VERTEX CARBORANE AND BORANE ELECTROLYTES, THEIR USE IN RECHARGABLE BATTERIES, AND PROCESSES FOR THEIR PREPARATION
20200313242 · 2020-10-01 ·

The present disclosure provides electrolytes for an electrochemical device. In some embodiments, these electrolytes are Mg salts comprising 10-vertex or 12-vertex carborane anions. The present disclosure also provides processes for preparing electrolytes for an electrochemical device. In some embodiments, the process comprises reduction of a reactive cation complexed with a 10-vertex or 12-vertex carborane or 12-vertex borate anion to form metal carborane or borate electrolytes. In some embodiments, the process comprises comproportionating a Mg.sup.+2 10-vertex or 12-vertex carborane salt to form a Mg.sup.+1 electrolyte comprising a 10-vertex or 12-vertex carborane. The present disclosure further provides electrochemical devices comprising the electrolytes disclosed herein. In some embodiments, the electrochemical device comprises an electrolyte that is stable at an electrical potential greater than 4 V vs Mg.sup.0/+2. Also provided herein are heterocyctes bearing the 10, 11, and 12 vertex carborane anions for application as catalyst and battery electrolyte components. The methods of making are also disclosed.